Body adiposity but not insulin resistance is associated with -675 4G/5G polymorphism in the PAI-1 gene in a sample of Mexican children

Ozel Demiralp, 2008, The effect of plasminogen activator inhibitor-1-675 4G/5G polymorphism on PAI-1 gene expression and adipocyte differentiation, Clin Appl Thromb Hemost., 14, 438, 10.1177/1076029607305081 Aso, 2007, Plasminogen activator inhibitor (PAI)-1 in vascular inflammation and thrombosis, Front Biosci., 12, 2957, 10.2741/2285 Binder, 2002, Plasminogen activator inhibitor 1: physiological and pathophysiological roles, News Physiol Sci., 17, 56 Ha, 2009, The role of plasminogen activator inhibitor 1 in renal and cardiovascular diseases, Nat Rev Nephrol., 5, 203, 10.1038/nrneph.2009.15 Ma, 2009, Plasminogen activator inhibitor-1 and asthma: role in the pathogenesis and molecular regulation, Clin Exp Allergy., 39, 1136, 10.1111/j.1365-2222.2009.03272.x Lopes, 2003, PAI-1 polymorphisms modulate phenotypes associated with the metabolic syndrome in obese and diabetic caucasian population, Diabetologia., 46, 1284, 10.1007/s00125-003-1170-0 Kruithof, 2008, Regulation of plasminogen activator inhibitor type 1 gene expression by inflammatory mediators and statins, Thromb Haemost., 100, 969, 10.1160/TH08-04-0269 Morange, 2007, Association of plasminogen activator inhibitor (PAI)-1 (SERPINE1) SNPs with myocardial infarction, plasma PAI- 1, and metabolic parameters: the HIFMECH study, Arterioscler Thromb Vasc Biol., 27, 2250, 10.1161/ATVBAHA.107.149468 Naran, 2008, The influence of metabolic syndrome components on plasma PAI-1 concentrations is modified by the PAI-1 4G/5G genotype and ethnicity, Atherosclerosis., 196, 155, 10.1016/j.atherosclerosis.2007.03.024 Bouchard, 2010, Contribution of genetic and metabolic syndrome to omental adipose tissue PAI-1 gene mRNA and plasma levels in obesity, Obes Surg., 20, 492, 10.1007/s11695-010-0079-1 Eriksson, 1995, Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction, Proc Natl Acad Sci U S A., 92, 1851, 10.1073/pnas.92.6.1851 McCormack, 1996, Promoter (4G/5G) plasminogen activator inhibitor-1 genotype in Pima Indians: relationship to plasminogen activator inhibitor-1 levels and features of the insulin resistance syndrome, Diabetologia., 39, 1512, 10.1007/s001250050606 Kershaw, 2004, Adipose tissue as an endocrine organ, J Clin Endocrinol Metab., 89, 2548, 10.1210/jc.2004-0395 Hoffstedt, 2002, The common -675 4G/5G polymorphism in the plasminogen activator inhibitor -1 gene is strongly associated with obesity, Diabetologia., 45, 584, 10.1007/s00125-001-0774-5 Silva-Zolezzi, 2009, Analysis of genomic diversity in Mexican mestizo populations to develop genomic medicine in Mexico, Proc Natl Acad Sci U S A., 106, 8611, 10.1073/pnas.0903045106 Ruiz-Quezada, 2004, Genotype and allele frequency of PAI-1 promoter polymorphism in healthy subjects from the west of Mexico, Association with biochemical and hematological parameters. Ann Genet., 47, 155 Nuño-Arana, 2005, High prevalence of 5G allele in Amerindian tribes and mestizos from Mexico at 4G/5G PAI-I gene promoter polymorphism, Thromb Haemost., 93, 1005, 10.1055/s-0037-1616576 Dawson, 1993, The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene respond differently to interleukin-1 in HepG2 cells, J Biol Chem., 268, 10739, 10.1016/S0021-9258(18)82047-6 Henry, 1997, Five frequent polymorphisms of the PAI-1 gene: lack of association between genotypes PAI activity, and triglyceride levels in a healthy population, Arterioscler Thromb Vasc Biol., 17, 851, 10.1161/01.ATV.17.5.851 Yamamoto, 1998, A pathological role of increased expression of plasminogen activator inhibitor-1 in human or animal disorders, Int J Hematol., 68, 371, 10.1016/S0925-5710(98)00094-2 Juhan-Vague, 2000, Hypofibrinolysis and increased PAI-1 are linked to atherothrombosis via insulin resistance and obesity, Ann Med., 32, 78 Bastard, 2000, Relationship between plasma plasminogen activator inhibitor 1 and insulin resistance, Diabetes Metab Res Rev., 16, 192, 10.1002/1520-7560(200005/06)16:3<192::AID-DMRR114>3.0.CO;2-G Morange, 2000, Influence of PAI-1 on adipose tissue growth and metabolic parameters in a murine model of diet-induced obesity, Arterioscler Thromb Vasc Biol., 20, 1150, 10.1161/01.ATV.20.4.1150 Schäfer, 2001, Disruption of the plasminogen activator inhibitor 1 gene reduces the adiposity and improves the metabolic profile of genetically obese and diabetic ob/ob mice, FASEB J., 15, 1840, 10.1096/fj.00-0750fje